GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intec Pharma Ltd (XTAE:NTEC) » Definitions » 12-1 Month Momentum %

Intec Pharma (XTAE:NTEC) 12-1 Month Momentum % : -21.23% (As of May. 25, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Intec Pharma 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-25), Intec Pharma's 12-1 Month Momentum % is -21.23%.

The industry rank for Intec Pharma's 12-1 Month Momentum % or its related term are showing as below:

XTAE:NTEC's 12-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: -25.71 vs XTAE:NTEC: -21.23

Competitive Comparison of Intec Pharma's 12-1 Month Momentum %

For the Biotechnology subindustry, Intec Pharma's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intec Pharma's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intec Pharma's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Intec Pharma's 12-1 Month Momentum % falls into.



Intec Pharma  (XTAE:NTEC) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intec Pharma  (XTAE:NTEC) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Intec Pharma 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Intec Pharma's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Intec Pharma (XTAE:NTEC) Business Description

Traded in Other Exchanges
N/A
Address
12 Hartom Street, Har Hotzvim, Jerusalem, ISR, 9777512
Intec Parent Inc, formerly Intec Pharma Ltd is a clinical-stage biopharmaceutical company based in Israel. The company is focused on research and development and clinical trials. The company develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing efficient gastric retention. Accordion Pill Carbidopa/Levodopa or AP-CDLD is being developed by the company for the indication of treatment of Parkinson's disease.